# A Study to Look at Day to Day Changes in Lung Function in COPD Subjects Taking Albuterol/Salbutamol and Ipratropium

> **NCT01691482** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 56 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** Albuterol/salbutamol
- **DRUG:** Ipratropium

## Key facts

- **NCT ID:** NCT01691482
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07-23
- **Primary completion:** 2012-10-01
- **Final completion:** 2012-10-22
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2018-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01691482

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01691482, "A Study to Look at Day to Day Changes in Lung Function in COPD Subjects Taking Albuterol/Salbutamol and Ipratropium". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01691482. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*